Senya
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
90 Tottenham Court Rd, London, Greater L...Website
www.senyatx.comRevenue
<$5 MillionIndustry
About Senya
Is Senya your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Senya has new funding data
Click to see if Senya had a recent Job posting/layoffs
Earning: See what the market has to say on Senya recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Senya has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Senya launches new products
Check out if Senya is spiking on competitors!
Senya, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Senya
Recommended Actions
Find VP level buyers at Senya
Find 2 more new buyers
Compare Similar Companies to Senya
Compare insights from companies similar to Senya, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Senya
Company Profile Activity
Activity Insights
Senya is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Senya is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Senya.
Senya Tech Stack
A closer look at the technologies used by Senya
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Senya
Senya Therapeutics is a pioneering company focused on developing an anti-leucine-rich α-2 glycoprotein 1 (LRG1) therapeutic platform to meet significant clinical needs in nephrology, oncology, pulmonary disease, and ophthalmology. Founded in 2023 as a spin-out from University College London, it leverages over 15 years of research and a robust paten... Read More